Pyruvate dehydrogenase activity and pyruvate dehydrogenase kinase 4 expression in skeletal muscle of end-stage renal disease patients

Chen-Qi XU; Lu-Lin MIN; Xiao-Huan CHEN; Ren-Hua LU; Ming-Li ZHU; Ke-Wei XIE; Ying-Ying QIAN; Xiang-Jiang GUO; Zhao-Hui NI; Kasimumali AYIJIAKEN; Le-Yi GU.
Journal of Shanghai Jiaotong University(Medical Science) ; (12): 305-309, 2018.
Artículo en Zh | WPRIM | ID: wpr-695660

Documentos relacionados

  1. Pyruvate dehydrogenase activity and pyruvate dehydrogenase kinase 4 expression in skeletal muscle of end-stage renal disease patients
  2. Reduction of mitochondria and up regulation of pyruvate dehydrogenase kinase 4 of skeletal muscle in patients with chronic kidney disease.
  3. Up-regulation of PRKDC was associated with poor renal dysfunction after renal transplantation: A multi-centre analysis.
  4. A randomized controlled comparative study of different fluid exchange modes in urgent-start peritoneal dialysis in patients with end-stage renal disease: automated peritoneal dialysis combined with manual fluid exchange vs. manual fluid exchange alone.
  5. Comparison of the hemoglobin variability in non-chronic kidney disease or end-stage renal disease participants and patients with CKD and ESRD.
  6. Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysis.
  7. Expression profiles of miR-129 and miR-29a-5p in vascular calcification of patients with end-stage renal disease and the underlying correlation.
  8. The Relationship Between Serum Fibroblast Growth Factor 23 and Klotho Protein and Low Bone Mineral Density in Middle-Aged and Elderly Patients with End-Stage Renal Disease.
  9. Investigation of APE1 and OGG1 expression in chronic hemodialysis patients.
  10. Plasma marinobufagenin immunoreactivity in patients with chronic kidney disease: a case control study.